Evading cell death

cancer
Cancer cell during cell division. Credit: National Institutes of Health

Cancer cells can develop resistance to the treatments designed to eliminate them. Several studies have linked stress granules (SGs), cell organelles that form transiently in response to extracellular stress, to this phenomenon. However, how SGs protect cancer cells remains unclear.

Susan Wente, Ph.D., and Laura Glass, Ph.D., report their establishment of an experimental cell culture model system to investigate the link between SGs and cell resistance to toxic stress in Advances in Biological Regulation.

Using their system, these investigators discovered altered SG biology in a subpopulation of cells that acquired resistance during multiple rounds of chemotoxic stress treatment. They further found that the protein Gle1A was required for the survival response and that secrete specific factors that confer treatment insensitivity to naïve cells.

These findings support a role for SGs in helping cells evade death. They also lay important groundwork for future investigations aimed at understanding and targeting SG-associated cell survival to improve cancer therapy efficacy.


Explore further

Studying cellular deliveries

More information: Laura Glass et al. Gle1 mediates stress granule-dependent survival during chemotoxic stress, Advances in Biological Regulation (2018). DOI: 10.1016/j.jbior.2018.09.007
Citation: Evading cell death (2018, November 9) retrieved 14 October 2019 from https://phys.org/news/2018-11-evading-cell-death.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more